Falcothou
- 29 May 2007 16:48
- 11 of 13
Quite an old thread but wonder if GSK represents an oversold buying opportunity. Noticed the other day that Mr. Bolton was anticipating a major market correction and was looking for ways to short and also buy into media and drugs companies, currently unfashionable places to be,
inma
- 01 Aug 2007 08:21
- 12 of 13
LONDON, July 31 (newratings.com) - Analysts at Dresdner Kleinwort reiterate their "buy" rating on GlaxoSmithKline Plc (GS7.FSE). The target price is set to 1,640p.